We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+12.61%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$58.7B
AUM Growth
+$5.6B
Cap. Flow
+$330M
Cap. Flow %
0.56%
Top 10 Hldgs %
15.44%
Holding
2,547
New
225
Increased
1,201
Reduced
957
Closed
144

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$150M
2
GDDY icon
GoDaddy
GDDY
+$129M
3
WYNN icon
Wynn Resorts
WYNN
+$106M
4
AIZ icon
Assurant
AIZ
+$104M
5
CNC icon
Centene
CNC
+$102M

Sector Composition

Rank Sector Weight
1 Technology 24.62%
2 Financials 13.49%
3 Consumer Discretionary 13.4%
4 Healthcare 13.12%
5 Industrials 12.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVNC
2301
DELISTED
Revance Therapeutics, Inc.
RVNC
$148K ﹤0.01%
+30,120
New +$178K
EHTH icon
2302
eHealth
EHTH
$39.1M
$148K ﹤0.01%
24,519
-51,099
-68% -$339K
SHO icon
2303
Sunstone Hotel Investors
SHO
$1.98B
$145K ﹤0.01%
13,006
+1,910
+17% +$20.9K
VLD
2304
DELISTED
Velo3D, Inc.
VLD
$144K ﹤0.01%
+9,034
New +$102K
FPI
2305
Farmland Partners
FPI
$425M
$143K ﹤0.01%
12,863
+229
+2% +$2.57K
MDXG icon
2306
MiMedx Group
MDXG
$630M
$142K ﹤0.01%
18,404
-3,914
-18% -$31.5K
NOVA
2307
DELISTED
Sunnova Energy
NOVA
$138K ﹤0.01%
+22,589
New +$204K
CRSR icon
2308
Corsair Gaming
CRSR
$1.39B
$137K ﹤0.01%
+11,122
New +$145K
ALXO icon
2309
ALX Oncology
ALXO
$267M
$134K ﹤0.01%
+11,999
New +$169K
CTKB icon
2310
Cytek Biosciences
CTKB
$616M
$134K ﹤0.01%
19,907
-36,299
-65% -$287K
LBAI
2311
DELISTED
Lakeland Bancorp Inc
LBAI
$130K ﹤0.01%
+10,705
New +$137K
IAS
2312
DELISTED
Integral Ad Science
IAS
$129K ﹤0.01%
12,971
-27,763
-68% -$371K
OLMA icon
2313
Olema Pharmaceuticals
OLMA
$913M
$129K ﹤0.01%
11,421
+640
+6% +$8.26K
MCRB icon
2314
Seres Therapeutics
MCRB
$46.6M
$129K ﹤0.01%
8,344
+6,961
+503% +$150K
EVC icon
2315
Entravision Communication
EVC
$852M
$125K ﹤0.01%
76,418
-224,697
-75% -$741K
KALV
2316
DELISTED
KalVista Pharmaceuticals
KALV
$125K ﹤0.01%
+10,538
New +$140K
SOUN icon
2317
SoundHound AI
SOUN
$3.29B
$124K ﹤0.01%
+20,977
New +$83.1K
NVRI icon
2318
Enviri
NVRI
$566M
$124K ﹤0.01%
13,502
+384
+3% +$3.23K
KOD icon
2319
Kodiak Sciences
KOD
$2.64B
$122K ﹤0.01%
+23,246
New +$114K
RLAY icon
2320
Relay Therapeutics
RLAY
$4.38B
$121K ﹤0.01%
14,550
+3,049
+27% +$29.7K
OPK icon
2321
Opko Health
OPK
$1.04B
$119K ﹤0.01%
99,439
-227,216
-70% -$227K
FIGS icon
2322
FIGS
FIGS
$2.37B
$118K ﹤0.01%
23,707
+1,674
+8% +$9.63K
LGF.A
2323
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$118K ﹤0.01%
+11,809
New +$117K
GDRX icon
2324
GoodRx Holdings
GDRX
$1.3B
$117K ﹤0.01%
16,418
-38,593
-70% -$255K
MQ icon
2325
Marqeta
MQ
$1.62B
$113K ﹤0.01%
+4,746
New +$117K

Similar funds

AQR Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, AQR Capital Management held 2,547 positions worth $58.7B, up 11% from $53.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

AQR Capital Management's Q1 2024 filing shows 225 new, 1,201 increased, 957 reduced and 144 closed positions. Its largest new stake was Snap: 4,386,413 shares worth $50.4M. The largest sale was TSMC, an estimated $672M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Consumer Discretionary.

  • AQR Capital Management's largest Q1 2024 buy was Snap: 4,386,413 shares worth $50.4M.
  • AQR Capital Management added most to Zoom in Q1 2024, an estimated $150M increase.
  • AQR Capital Management's biggest Q1 2024 reduction was TSMC, cutting an estimated $672M.
  • AQR Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $9.79M.
  • AQR Capital Management's ten largest holdings make up 15% of its $58.7B portfolio in Q1 2024.
  • AQR Capital Management opened 225 new positions and closed 144 in Q1 2024.
  • AQR Capital Management's portfolio value rose 11% quarter-over-quarter to $58.7B.

Based on AQR Capital Management's 13F filing for Q1 2024, filed 15 May 2024.